Related references
Note: Only part of the references are listed.Precision Medicine for Intracranial Atherosclerotic Disease
David S. Liebeskind
FRONTIERS IN NEUROLOGY (2021)
Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments
Takayasu Mishima et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Virtual reality in research and rehabilitation of gait and balance in Parkinson disease
Colleen G. Canning et al.
NATURE REVIEWS NEUROLOGY (2020)
Botulinurn toxin type A therapy for cervical dystonia
Filipe B. Rodrigues et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Prevalence of psychiatric disorders in patients with inherited or idiopathic dystonia
Benedetta Demartini et al.
PARKINSONISM & RELATED DISORDERS (2018)
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study
Pamela Latino et al.
NEUROLOGICAL SCIENCES (2017)
Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin
Maria Fiorella Contarino et al.
FRONTIERS IN NEUROLOGY (2017)
Botulinumtoxin type A therapy for cervical dystonia
Mafalda Castelao et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes
H. A. Jinnah et al.
JOURNAL OF NEUROLOGY (2016)
Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia
Michele Poliziani et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
An international survey of patients with cervical dystonia
Cynthia Comella et al.
JOURNAL OF NEUROLOGY (2015)
Precision Medicine - Personalized, Problematic, and Promising
J. Larry Jameson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation
Craig Lockwood et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia
Virgilio Gerald H. Evidente et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Phenomenology and classification of dystonia: A consensus update
Alberto Albanese et al.
MOVEMENT DISORDERS (2013)
Continuation of Long-Term Care for Cervical Dystonia at an Academic Movement Disorders Clinic
Chandler E. Gill et al.
TOXINS (2013)
The use of botulinum toxin type A in the management of adult-onset focal spasticity: A survey of Australian allied health professionals
Gavin Williams et al.
AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL (2012)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Treatment of cervical dystonia with botulinum toxins
CL Comella et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
P Haussermann et al.
MOVEMENT DISORDERS (2004)
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
GYR Hsiung et al.
MOVEMENT DISORDERS (2002)
Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: A comparative study between a home and a clinic treatment service
J Whitaker et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2001)
Share Paper
